Why doesn't the US have better sunscreen?
About this episode
The episode discusses the slow approval process of new sunscreens by the FDA and features a skincare influencer advocating for change.
Why has the Food and Drug Administration taken so long to approve new sunscreens? Unlike the rest of the world, the FDA only just approved its first new ingredient in nearly three decades. We learn about a proposal to speed up drug and sunscreen innovation, and a skincare influencer who lobbied for change. Fact checking by Sierra Juarez . Your Next Listen — The sneaky way companies get new chemicals into our food Connect with The Indicator — Sign up for The Indicator’s weekly newsletter ! — Buy the Planet Money book — Find our socials, YouTube and more ! — For sponsor-free episodes, subscribe to NPR+ See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy
Topics covered
- sunscreen
- FDA approval
- skincare
- drug innovation
- lobbying
Keywords
- sunscreen
- FDA
- skincare influencer
- drug innovation
- lobbying
Mentioned in this episode
Organizations: Food and Drug Administration, Planet Money
More episodes of The Indicator from Planet Money
- Tale of Two Cities
- New NPR Series: "We Keep Us Safe" from the Embedded podcast
- The Strait of Hormuz no-fee, China cuts down on pollution and IMAX's economic Odyssey
- Why the Pope wants to disarm AI
- Why your neighbor might be paying less for their car
- Can the internet survive AI summaries?
Explore listener stats, chart rankings, contacts and more on the The Indicator from Planet Money podcast page.